Cytokine Patterns During Dengue Shock Syndrome
Overview
Authors
Affiliations
Objective: To investigate the patterns of tumor necrosis factor-alpha (TNF-alpha), interleukin-1beta (IL-1beta), IL-6, interferon-gamma (IFN-gamma) and interleukin-1 receptor antagonist (IL-1Ra) during the course of dengue shock syndrome.
Design: Prospective clinical study.
Setting: Pediatric Intensive Care Unit, Dr. Kariadi Hospital, the university hospital of Diponegoro University, Semarang, Indonesia.
Patients: Fifty children with dengue shock syndrome.
Measurements: The plasma concentration and the ex vivo production, with and without lipopolysaccharide (LPS), of TNF-alpha, IL-1beta and IL-1Ra were measured in duplicate by nonequilibrium radioimmunoassay (RIA); IFN-gamma and IL-6 were measured by ELISA.
Results: During the acute phase, the plasma concentrations and the ex vivo production without LPS of IL-1Ra were considerably elevated and returned to normal on recovery. However, the ex vivo LPS-stimulated production of the proinflammatory cytokines TNF-alpha and IL-1beta were considerably depressed. Also, these concentrations returned towards normal on recovery. In non-survivors, the plasma concentrations of IL-6 and IL-1Ra were significantly higher than in survivors (p = 0.00001 and p = 0.0005, respectively). In addition, the ex vivo production of IL-1Ra in non-survivors was significantly higher than in survivors, both without LPS stimulation (p = 0.0008) and with LPS (p < 0.004). IL-1Ra was significantly associated with mortality (p = 0.007).
Conclusion: Since IL-1Ra was significantly associated with mortality, this measurement may be used as an index of disease severity in dengue shock syndrome.
McBride A, Le Duyen H, Vuong N, Tho P, Tai L, Phong N PLoS Negl Trop Dis. 2024; 18(3):e0012071.
PMID: 38536887 PMC: 11020502. DOI: 10.1371/journal.pntd.0012071.
IL-6 Levels in Prediction of Severity of Dengue Fever.
Vachher H, Metgud T, Srikanth B Indian J Pediatr. 2023; 90(5):518.
PMID: 36848012 DOI: 10.1007/s12098-023-04514-y.
Dengue Virus Infection: A Tale of Viral Exploitations and Host Responses.
Nanaware N, Banerjee A, Bagchi S, Bagchi P, Mukherjee A Viruses. 2021; 13(10).
PMID: 34696397 PMC: 8541669. DOI: 10.3390/v13101967.
Balanza N, Erice C, Ngai M, Varo R, Kain K, Bassat Q Front Pediatr. 2020; 8:552083.
PMID: 33072673 PMC: 7530621. DOI: 10.3389/fped.2020.552083.
Marin-Palma D, Sirois C, Urcuqui-Inchima S, Hernandez J PLoS One. 2019; 14(3):e0214245.
PMID: 30901375 PMC: 6430398. DOI: 10.1371/journal.pone.0214245.